Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 18,156
- Companies
- 1,062
- Drugs tracked
- 3,385
Quick answer
NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Lactobacillus plantarum IS-10506
United Therapeutics Europe Ltd
Constipation - Functional
1 trial -
Lactose Placebo
United Therapeutics Europe Ltd
Elbow Fracture
1 trial -
Low Frequency Right sided repetitive transcranial magnetic stimulation (LFR rTMS)
United Therapeutics Europe Ltd
TBI Depression
1 trial -
MRI
United Therapeutics Europe Ltd
Prostate Neoplasm
1 trial -
Metformin
United Therapeutics Europe Ltd
Idiopathic Pulmonary Fibrosis
1 trial -
Metoprolol succinate
United Therapeutics Europe Ltd
Pulmonary Disease, Chronic Obstructive
1 trial -
Mirasol-treated Fresh Whole Blood
United Therapeutics Europe Ltd
Transfusion-Transmitted Infectious Disease
1 trial -
Mitomycin-C
United Therapeutics Europe Ltd
Corneal Opacity
1 trial -
Moxifloxacin
United Therapeutics Europe Ltd
Chronic Obstructive Pulmonary Disease (COPD).
1 trial -
New thickened formula
United Therapeutics Europe Ltd
Gastroesophageal Reflux
1 trial -
Niclosamide
United Therapeutics Europe Ltd
Covid19
1 trial -
Nicotinomide
United Therapeutics Europe Ltd
Glaucoma, Open-Angle
1 trial -
Nutritional supplements
United Therapeutics Europe Ltd
Low Birth Weight
1 trial -
Obinutuzumab
United Therapeutics Europe Ltd
Non-Hodgkin's Lymphoma
1 trial -
Ondansetron
United Therapeutics Europe Ltd
IBS - Irritable Bowel Syndrome
1 trial -
Oral Co-trimoxazole (8mg/kg/day trimithoprim) twice a day for five days vs. oral amoxycillin (20 mg/kg/day) thrice a day for three days.
United Therapeutics Europe Ltd
Non-Severe Pneumonia
1 trial -
Oral Treprostinil
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
2 trials -
Oral Treprostinil
United Therapeutics Europe Ltd
Pulmonary Hypertension Associated With Sickle Cell Disease
1 trial -
Oral treprostinil
United Therapeutics Europe Ltd
Pulmonary Hypertension
2 trials -
Oral treprostinil (UT-15C) sustained release tablets
United Therapeutics Europe Ltd
Pulmonary Hypertension
2 trials -
Oxandrolone
United Therapeutics Europe Ltd
Trauma Injury
1 trial -
Oxybutynin Chloride
United Therapeutics Europe Ltd
Breast Carcinoma
1 trial -
PRO 2000/5
United Therapeutics Europe Ltd
HIV Infections
1 trial -
Pembrolizumab 25 MG/ML [Keytruda]
United Therapeutics Europe Ltd
Lung Cancer, Nonsmall Cell
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources